| Literature DB >> 30355193 |
Shadi Yaghi1, Andrew D Chang1, Shawna Cutting1, Mahesh Jayaraman1,2,3, Ryan A McTaggart2, Brittany A Ricci1, Katarina Dakay1, Priya Narwal1, Brian Mac Grory1, Tina Burton1, Michael Reznik1, Brian Silver4, Ajay Gupta5, Christopher Song6, Emile Mehanna6, Matthew Siket7, Michael P Lerario8, Daniel C Saccetti9, Alexander E Merkler9, Hooman Kamel9, Mitchell S V Elkind10, Karen Furie1.
Abstract
Background and Purpose- Transthoracic echocardiography (TTE) is widely used in the ischemic stroke setting. In this study, we aim to investigate the yield of TTE in patients with ischemic stroke and known subtype and whether the admission troponin level improves the yield of TTE. Methods- Data were abstracted from a single-center prospective ischemic stroke database for 18 months and included all patients with ischemic stroke whose etiologic subtype could be obtained without the need of TTE. Unadjusted and adjusted regression models were built to determine whether positive cardiac troponin levels (≥0.1 ng/mL) improve the yield of TTE, adjusting for demographic and clinical characteristics. Results- We identified 578 patients who met the inclusion criteria. TTE changed clinical management in 64 patients (11.1%), but intracardiac thrombus was detected in only 4 patients (0.7%). In multivariable models, there was an association between TTE changing management and positive serum troponin level (adjusted odds ratio, 4.26; 95% CI, 2.17-8.34; P<0.001). Conclusions- In patients with ischemic stroke, TTE might lead to a change in clinical management in ≈1 of 10 patients with known stroke subtype before TTE but changed acute treatment decisions in <1 percent of patients. Serum troponin levels improved the yield of TTE in these patients.Entities:
Keywords: echocardiography; heart disease; humans; stroke; troponin
Mesh:
Substances:
Year: 2018 PMID: 30355193 PMCID: PMC6209115 DOI: 10.1161/STROKEAHA.118.022477
Source DB: PubMed Journal: Stroke ISSN: 0039-2499 Impact factor: 7.914